FDA Approved: LITHIUM CARBONATE — Original Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Camber Pharmaceuticals' lithium carbonate as a generic, marking the Original Application under ANDA090702 for market authorization.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Lithium carbonate (Lithium carbonate)

Snippet

ORIG AP for LITHIUM CARBONATE (LITHIUM CARBONATE)